Kirke Weaver - Mar 31, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role: Gen. Counsel & Corp. Secy.
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Kirke Weaver
Stock symbol: OGN
Transactions as of: Mar 31, 2023
Transactions value $: -$48,835
Form type: 4
Date filed: 4/4/2023, 08:21 PM
Previous filing: Mar 2, 2023
Next filing: May 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise	$0	+7.42K	+135.36%	$0.00	12.9K	Mar 31, 2023	Direct
transaction	OGN	Common Stock	Tax liability	-$48.8K	-2.12K	-16.4%	$23.09	10.8K	Mar 31, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-7.42K	-33.33%	$0.00	14.8K	Mar 31, 2023	Common Stock	7.42K		Direct	F1, F2
transaction	OGN	Stock Option (right to buy)	Award	$0	+66.8K		$0.00	66.8K	Mar 31, 2023	Common Stock	66.8K	$23.52	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
F2	On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025.
F3	The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026.